AI
How Abridge’s $5.3B AI Surge Is Transforming Clinical Documentation and Revenue Cycles in U.S. Healthcare
Key Insights: Andreessen Horowitz Leads $300M Bet on Abridge’s Healthcare AI VisionAndreessen Horowitz (A16z) has doubled down on…
Why Sutter Health’s Strategic AI Partnership with Aidoc Could Set the Benchmark for System-Wide Clinical Intelligence in U.S. Healthcare
Key Highlights Strategic Collaboration to Scale Clinical AISutter Health has announced a multi-year strategic partnership with Aidoc, embedding…
Is Sanofi’s $632M AI Bet on Formation Bio the Next Big Immunology Breakthrough?
French pharma giant doubles down on AI-native R&D with gusacitinib licensing deal targeting new inflammatory indication Key Takeaways…
Can Tampa General’s New AI Ambient Tech Redefine Nurse Workflows and Patient Experience?
AI-powered voice technology by Microsoft brings ambient documentation to frontline nurses, boosting care quality and clinical efficiency Key…

Is AstraZeneca’s $20M AI Hub in Bengaluru the Catalyst for 20 New Medicines by 2030?
Key Highlights Strategic Investment to Scale AI-Driven InnovationAstraZeneca has inaugurated a state-of-the-art Global Hub in Bengaluru with an…
Will Samsung’s Acquisition of Xealth Spark a New Era of AI-Driven Mobile Healthcare in the U.S.?
Key Highlights Samsung Expands into AI Healthcare with Xealth DealSamsung Electronics has announced its acquisition of Xealth, a…